Inventor · Strasbourg, FR

Marie-Paule Kieny

18Patents
8h-index
17Co-inventors
65Inventor score

Filing activity: Sep 24, 1991 → Dec 8, 2008

Most-cited inventions

PatentTitleAreaCited byStatus
US6007806A Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor Chemistry; Metallurgy 47 Expired
US5795577A Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S. Emerging Cross-Sectional Technologies 28 Expired
US5744133A Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor Emerging Cross-Sectional Technologies 23 Expired
US6884786B1 Antitumoral composition based on immunogenic polypeptide with modified cell location Chemistry; Metallurgy 22 Expired
US5861381A Pharmaceutical composition for the treatment of a malignant tumor Human Necessities 20 Expired
US7488482B2 Pharmaceutical compositions for treating papillomavirus tumors and infection Chemistry; Metallurgy 15 Active
US5169763A Viral vector coding glycoprotein of HIV-1 Emerging Cross-Sectional Technologies 14 Expired
US7118754B1 Pharmaceutical composition for treating papillomavirus tumors and infection Chemistry; Metallurgy 10 Expired
US5597570A Protein recognized by antibodies raised against native P28 of schistosoma mansoni Emerging Cross-Sectional Technologies 5 Expired
US5830477A Vaccine against rabies and process for preparation thereof Chemistry; Metallurgy 5 Expired
US6024953A Vaccine against rabies and process for preparation thereof Chemistry; Metallurgy 4 Expired
US7670607B2 Pharmaceutical compositions for treating papillomavirus tumors and infection Chemistry; Metallurgy 3 Active
US5672689A Non-cleavable GP160 glycoproteins of HIV Emerging Cross-Sectional Technologies 2 Expired
US7332478B2 Antitumoral composition based on immunogenic polypeptide with modified cell location Chemistry; Metallurgy 2 Expired
US6261799A Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants Chemistry; Metallurgy 1 Expired
US6203795A Pharmaceutical composition for the treatment or prevention of a malignant tumor Human Necessities 1 Expired
US6328956A Pharmaceutical composition for the treatment or prevention of a malignant tumor Human Necessities 0 Expired
US6284248A Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.